APA (7th ed.) Citation

R, R., C, P., F, A., V, B., S, B., G, B., . . . E, R. (2026). Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy. Neurology and therapy, 15(1), 213. https://doi.org/10.1007/s40120-025-00860-5

Chicago Style (17th ed.) Citation

R, Roberti, et al. "Lacosamide Is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy." Neurology and Therapy 15, no. 1 (2026): 213. https://doi.org/10.1007/s40120-025-00860-5.

MLA (9th ed.) Citation

R, Roberti, et al. "Lacosamide Is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy." Neurology and Therapy, vol. 15, no. 1, 2026, p. 213, https://doi.org/10.1007/s40120-025-00860-5.